Special Report – Stability Studies
The extended stability studies of anticancer therapies published in 2024 cover 21 small molecules across nine parenteral drug groups in oncology.
Select the oncology parenteral groups:
Select up to three molecules:
Results:
Select the oncology parenteral groups and molecules to see the results
